Deep learning and NLP for predicting and understanding neurological disease.
St George’s and LSHTM (both University of London) have partnered with Novoic to offer a unique interdisciplinary PhD at the intersection of computational linguistics, deep learning and neurology. This research will lead to a new understanding of how speech is affected in disease and provide the basis for a powerful new class of diagnostic tools for patients.
The project will involve developing methods to enhance the interpretability of speech- and language-based ML models for disease prediction, using state-of-the-art techniques from computational linguistics, image processing and deep learning.
You’ll have access to a large, one-of-a-kind dataset combining speech recordings, MR imaging, disease diagnoses, and neuropsychological and neurolinguistic test scores. This will include a placement researching at Novoic, a London-based digital biotech startup (https://novoic.com).
Applicants should have an undergraduate/master’s degree in Computer Science or ML and an interest in the analysis of speech/language. More details about the PhD can be found here:
Apply here by 1st January: http://mrc-lid.lshtm.ac.uk/apply/
Novoic is a London-based digital biotech company predicting brain disease from the way you speak – decades before routine diagnosis. Our research lies at the intersection of computational linguistics, deep learning and neuroscience. We believe having your brain health checked should be as easy as having a conversation. Our team has a diverse range of backgrounds, including Oxford/Cambridge researchers, clinicians and the former CEO of a top-5 global pharmaceutical company. Novoic is backed by Entrepreneur First, the leading talent investor in Europe, and the Oxford University L.E.V8 accelerator.